tirzepatide fda approves tirzepatide, Eli Lilly's new type 2 diabetes drug, and the company shares an estimated price FDA Says Shortage of GLP-1

Protein guidance is provided at initiation because GLP-1-driven appetite suppression reduces caloric intake broadly without adequate protein (typically 1.21.6g per kg body weight), you lose muscle alongside fat, and that's both metabolically and aesthetically wrong

While not officially approved for weight loss, its sometimes prescribed off-label for that purpose

100% Natural | Gluten-Free | Vegan | No Corn Syrup

Thats because theyve already been so widely accepted in treating diabetes and obesity

Stick to bland, plain options like grilled chicken, firm tofu, white rice, and clear broths during days when your nausea peaks